The legislation comes in reaction to a law that was geared toward protecting consumer privacy. Drug companies say, though, that it could inadvertently invalidate research, make it difficult to obtain funding and ultimately drive scientists from the state. In other industry news, companies in Massachusetts are being wooed by Maryland, and Europe signs off on another Humira copy.
from Kaiser Health News https://ift.tt/2OImnIF
September 20, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
A New Privacy Threat?: Study Shows How Facial Recognition Software Identifies Patients From MRI ScansWhile there's a big push to mine medical data from patient records, research, medical devices and technology such as smartwatches, privacy protections don't appear to go far enough, according to new research. Other news on he… Read More
Los Angeles Vape District A Black-Market GatewayA five-block section of downtown Los Angeles that used to be part of the city’s Toy District has become ground zero for the nation’s counterfeit cannabis trade. While a few remaining stores sell fidget spinners and stuffed an… Read More
First Edition: October 25, 2019Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/32SkgsQ … Read More
State Highlights: Colorado Mother Arrested On Murder Charges After Making Up Daughter’s ‘Rare’ Medical Conditions; Lists Of Connecticut Schools Short On Vaccines Grows To 134Media outlets report on news from Colorado, Connecticut, California, Pennsylvania, Washington, New York, Maryland, North Carolina, Ohio, Massachusetts, Iowa, Utah and Arizona. from Kaiser Health News https://ift.tt/2MHCyHw … Read More
Viewpoints: Pros And Cons Of Biogen’s Decision To Reevaluate Alzheimer’s Drug; Isn’t It Really Time To Criminally Prosecute Companies Behind Opioid Epidemic?Editorial writers express views on these health issues and others. from Kaiser Health News https://ift.tt/33ZoC1a … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment